Characterization of an Infectious Cdna Copy of the Genome of a Naturally Occurring, Avirulent Coxsackievirus B3 Clinical Isolate
暂无分享,去创建一个
N. Chapman | S. Tracy | K. Drescher | C. Lee | E. Haas | K.-S. Kim | Kono
[1] S. Tracy,et al. Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection. , 2004, Virology.
[2] W. Melchers,et al. Mutational Analysis of Different Regions in the Coxsackievirus 2B Protein , 2004, Journal of Biological Chemistry.
[3] B. Semler,et al. Strand-Specific RNA Synthesis Determinants in the RNA-Dependent RNA Polymerase of Poliovirus , 2004, Journal of Virology.
[4] P. E. Tam,et al. Multiple Viral Determinants Mediate Myopathogenicity in Coxsackievirus B1-Induced Chronic Inflammatory Myopathy , 2003, Journal of Virology.
[5] D. Wuttke,et al. Towards an understanding of the poliovirus replication complex: the solution structure of the soluble domain of the poliovirus 3A protein. , 2003, Journal of molecular biology.
[6] Michael Zuker,et al. Mfold web server for nucleic acid folding and hybridization prediction , 2003, Nucleic Acids Res..
[7] N. Chapman,et al. The stem loop II within the 5' nontranslated region of clinical coxsackievirus B3 genomes determines cardiovirulence phenotype in a murine model. , 2003, The Journal of infectious diseases.
[8] A. Bruu. Enteroviruses: Polioviruses, Coxsackieviruses, Echoviruses and Newer Enteroviruses , 2003 .
[9] P. Minor. Polio vaccines and the cessation of vaccination , 2003, Expert review of vaccines.
[10] B. McManus,et al. A shine-dalgarno-like sequence mediates in vitro ribosomal internal entry and subsequent scanning for translation initiation of coxsackievirus B3 RNA. , 2003, Virology.
[11] N. Chapman,et al. Toward Testing the Hypothesis that Group B Coxsackieviruses (CVB) Trigger Insulin-Dependent Diabetes: Inoculating Nonobese Diabetic Mice with CVB Markedly Lowers Diabetes Incidence , 2002, Journal of Virology.
[12] J. Galama,et al. Biological Significance of a Human Enterovirus B-Specific RNA Element in the 3′ Nontranslated Region , 2002, Journal of Virology.
[13] T. Kanno,et al. Virulence of swine vesicular disease virus is determined at two amino acids in capsid protein VP1 and 2A protease. , 2001, Virus research.
[14] Michael G. Rossmann,et al. Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor , 2001, Nature Structural Biology.
[15] R. Zell,et al. Expression of Immunoregulatory Cytokines by Recombinant Coxsackievirus B3 Variants Confers Protection against Virus-Caused Myocarditis , 2001, Journal of Virology.
[16] Shelton S. Bradrick,et al. A Predicted Secondary Structural Domain within the Internal Ribosome Entry Site of Echovirus 12 Mediates a Cell-Type-Specific Block to Viral Replication , 2001, Journal of Virology.
[17] E. Wimmer,et al. The C-terminal residues of poliovirus proteinase 2A(pro) are critical for viral RNA replication but not for cis- or trans-proteolytic cleavage. , 2001, The Journal of general virology.
[18] N. Chapman,et al. Coxsackievirus Expression of the Murine Secretory Protein Interleukin-4 Induces Increased Synthesis of Immunoglobulin G1 in Mice , 2000, Journal of Virology.
[19] K. Höfling,et al. Group B coxsackievirus myocarditis and pancreatitis: Connection between viral virulence phenotypes in mice , 2000, Journal of medical virology.
[20] N. Chapman,et al. Genomic Determinants of Cardiovirulence in Coxsackievirus B3 Clinical Isolates: Localization to the 5′ Nontranslated Region , 2000, Journal of virology.
[21] J. Meredith,et al. Identification of a cis-Acting Replication Element within the Poliovirus Coding Region , 2000, Journal of Virology.
[22] N. Chapman,et al. Expression of an Antigenic Adenovirus Epitope in a Group B Coxsackievirus , 2000, Journal of Virology.
[23] B. Semler,et al. A Group B Coxsackievirus/Poliovirus 5′ Nontranslated Region Chimera Can Act as an Attenuated Vaccine Strain in Mice , 2000, Journal of Virology.
[24] A. Ramsingh,et al. A point mutation in VP1 of coxsackievirus B4 alters antigenicity. , 2000, Virology.
[25] R. Andino,et al. Interactions of Viral Protein 3CD and Poly(rC) Binding Protein with the 5′ Untranslated Region of the Poliovirus Genome , 2000, Journal of Virology.
[26] B. McManus,et al. Structural and functional analysis of the 5' untranslated region of coxsackievirus B3 RNA: In vivo translational and infectivity studies of full-length mutants. , 1999, Virology.
[27] S. Martin,et al. Functional features of the bovine enterovirus 5'-non-translated region. , 1999, The Journal of general virology.
[28] S. Yamaguchi,et al. Mapping the Genetic Determinants of Pathogenicity and Plaque Phenotype in Swine Vesicular Disease Virus , 1999, Journal of Virology.
[29] G. Clements,et al. Simultaneous onset of Type 1 diabetes mellitus in identical infant twins with enterovirus infection , 1998, Diabetic medicine : a journal of the British Diabetic Association.
[30] H. Hyöty,et al. Enterovirus infections and insulin dependent diabetes mellitus--evidence for causality. , 1998, Clinical and diagnostic virology.
[31] A. Ramsingh. Coxsackieviruses and pancreatitis. , 1997, Frontiers in bioscience : a journal and virtual library.
[32] J. Hansen,et al. Structure of the RNA-dependent RNA polymerase of poliovirus. , 1997, Structure.
[33] N. Chapman,et al. Generation of an infectious cDNA of a highly cardiovirulent coxsackievirus B3(CVB3m) and comparison to other infectious CVB3 cDNAs. , 1997, Virus research.
[34] B. Semler,et al. Requirement of poly(rC) binding protein 2 for translation of poliovirus RNA , 1997, Journal of virology.
[35] S. Huber. Autoimmunity in myocarditis: relevance of animal models. , 1997, Clinical immunology and immunopathology.
[36] R. Wessely,et al. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3 , 1996, Journal of virology.
[37] B. Semler,et al. Determinants of Membrane Association for Poliovirus Protein 3AB* , 1996, The Journal of Biological Chemistry.
[38] R. Jackson,et al. Internal initiation of translation in eukaryotes: the picornavirus paradigm and beyond. , 1995, RNA.
[39] D. N. Collins,et al. A point mutation in the VP4 coding sequence of coxsackievirus B4 influences virulence , 1995, Journal of virology.
[40] P. Hofschneider,et al. Characterization of a 100-kilodalton binding protein for the six serotypes of coxsackie B viruses , 1995, Journal of virology.
[41] K. Currey,et al. The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5' nontranslated region , 1995, Journal of virology.
[42] M G Rossmann,et al. The structure of coxsackievirus B3 at 3.5 A resolution. , 1995, Structure.
[43] B. Strauer,et al. Identification of serotype-specific and nonserotype-specific B-cell epitopes of coxsackie B virus using synthetic peptides. , 1994, Virology.
[44] P. Auvinen,et al. Mapping of antigenic sites of coxsackievirus B3 by synthetic peptides , 1993, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[45] R. Brookmeyer,et al. The evolution of virus diseases: their emergence, epidemicity, and control. , 1993, Virus research.
[46] J. McCauley,et al. Complete nucleotide sequence of a coxsackie B5 virus and its relationship to swine vesicular disease virus. , 1993, The Journal of general virology.
[47] S. Le,et al. Conserved tertiary structure elements in the 5′ untranslated region of human enteroviruses and rhinoviruses , 1992, Virology.
[48] P. Minor. The molecular biology of poliovaccines. , 1992, The Journal of general virology.
[49] D. Stone,et al. Correlation of RNA secondary structure and attenuation of Sabin vaccine strains of poliovirus in tissue culture. , 1992, Virology.
[50] R. Gómez,et al. Murine acinar pancreatitis preceding necrotizing myocarditis after coxsackievirus B3 inoculation , 1991, Journal of medical virology.
[51] H. Yonekawa,et al. Nucleotide sequences important for translation initiation of enterovirus RNA , 1991, Journal of virology.
[52] E. Myers,et al. Basic local alignment search tool. , 1990, Journal of molecular biology.
[53] M. Pallansch,et al. Echovirus 22 is an atypical enterovirus , 1990, Journal of virology.
[54] A. Ramsingh,et al. Evidence suggesting that virulence maps to the P1 region of the coxsackievirus B4 genome , 1990, Journal of virology.
[55] A. Nomoto,et al. Determinants in the 5' noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype , 1989, Journal of virology.
[56] A. Nomoto,et al. A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain , 1988, Journal of virology.
[57] D. Filman,et al. Three-dimensional structure of poliovirus serotype 1 neutralizing determinants , 1988, Journal of virology.
[58] J. Icenogle,et al. Antigenic structure of polioviruses of serotypes 1, 2 and 3. , 1986, The Journal of general virology.
[59] N. Bowles,et al. DETECTION OF COXSACKIE-B-VIRUS-SPECIFIC RNA SEQUENCES IN MYOCARDIAL BIOPSY SAMPLES FROM PATIENTS WITH MYOCARDITIS AND DILATED CARDIOMYOPATHY , 1986, The Lancet.
[60] I. Talbot,et al. Severe Pancreatitis and Fatty Liver Progressing to Cirrhosis Associated with Coxsackie B4 Infection in a Three Year Old with Alpha‐1‐Antitrypsin Deficiency , 1986, Acta paediatrica Scandinavica.
[61] B. Sherry,et al. Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14 , 1986, Journal of virology.
[62] P. Hofschneider,et al. Molecular cloning of the genome of a cardiotropic Coxsackie B3 virus: full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[63] J. Maizel,et al. Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome , 1985, Nature.
[64] B. Sherry,et al. Evidence for at least two dominant neutralization antigens on human rhinovirus 14 , 1985, Journal of virology.
[65] M. Kaplan,et al. Group B coxsackievirus infections in infants younger than three months of age: a serious childhood illness. , 1983, Reviews of infectious diseases.
[66] T. Mertens,et al. Neutralizing antibodies against Coxsackie B viruses in patients with recent onset of type I diabetes , 1983, European Journal of Pediatrics.
[67] C. Gauntt,et al. Temperature-Sensitive Mutant of Coxsackievirus B3 Establishes Resistance in Neonatal Mice That Protects Them During Adolescence Against Coxsackievirus B3-Induced Myocarditis , 1983, Infection and immunity.
[68] N. Nathanson,et al. The epidemiology of poliomyelitis: enigmas surrounding its appearance, epidemicity, and disappearance. , 1979, American journal of epidemiology.
[69] J. C. Ferguson,et al. Coxsackie and mumpsvirus infection in a prospective study of acute pancreatitis. , 1977, Gut.
[70] F. Brown,et al. Antigenic Differences between Isolates of Swine Vesicular Disease Virus and their Relationship to Coxsackie B5 Virus , 1973, Nature.
[71] B. Ursing. Acute pancreatitis in coxsackie B infection. , 1973, British medical journal.
[72] F. Cole,et al. Isolation of a Coxsackie virus group B, type 5, from the heart of a fatal case of myocarditis in an adult , 1969, Journal of clinical pathology.
[73] K. Benirschke,et al. Severe generalized disease (encephalohepatomyocarditis) occurring in the newborn period and due to infection with Coxsackie virus, group B; evidence of intrauterine infection with this agent. , 1958, Pediatrics.
[74] A. Sabin. CHARACTERISTICS AND GENETIC POTENTIALITIES OF EXPERIMENTALLY PRODUCED AND NATURALLY OCCURRING VARIANTS OF POLIOMYELITIS VIRUS , 1955, Annals of the New York Academy of Sciences.
[75] M. Disney,et al. Bornholm Disease in Children , 1953, British medical journal.
[76] E. W. Shaw,et al. A Virus Isolated from Patients Diagnosed as Non-Paralytic Poliomyelitis or Aseptic Meningitis.∗ , 1949, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[77] N. Chapman,et al. Coxsackievirus B3 from an infectious cDNA copy of the genome is cardiovirulent in mice , 2005, Archives of Virology.
[78] N. Chapman,et al. An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain: its complete sequence analysis and comparison to the genomes of cardiovirulent coxsackieviruses , 2005, Archives of Virology.
[79] D. Kerrigan,et al. Structure and function analysis of the poliovirus cis-acting replication element (CRE). , 2003, RNA.
[80] K. Currey,et al. Mutations in a conserved enteroviral RNA oligonucleotide sequence affect positive strand viral RNA synthesis , 2000, Archives of Virology.
[81] J. McCauley,et al. Coxsackievirus B5 and the relationship to swine vesicular disease virus. , 1997, Current topics in microbiology and immunology.
[82] J. Romero,et al. Genetic divergence among the group B coxsackieviruses. , 1997, Current topics in microbiology and immunology.
[83] R. Ren,et al. Poliovirus biology and pathogenesis. , 1996, Current topics in microbiology and immunology.
[84] T. Martino,et al. Enteroviral Myocarditis and Dilated Cardiomyopathy: a Review of Clinical and Experimental Studies , 1995 .
[85] A. Moraska,et al. T lymphocyte responses in CVB3-induced murine myocarditis. , 1993, Scandinavian journal of infectious diseases. Supplementum.
[86] S. R. Pollard,et al. Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates. , 1993, Virology.
[87] S. Baekkeskov,et al. The 64-kDa beta cell membrane autoantigen and other target molecules of humoral autoimmunity in insulin-dependent diabetes mellitus. , 1990, Current topics in microbiology and immunology.
[88] V. Racaniello. Poliovirus neurovirulence. , 1988, Advances in Virus Research.
[89] E. Nordenfelt,et al. Enterovirus infections in acute pancreatitis - a possible etiological connection. , 1976, Scandinavian journal of gastroenterology.
[90] A. Sabin,et al. History of Sabin attenuated poliovirus oral live vaccine strains , 1973 .
[91] S. V. van Creveld,et al. Myocarditis in newborns, caused by coxsackie virus; clinical and pathological data. , 1956, Annales paediatrici. International review of pediatrics.
[92] G. Dalldorf. The Coxsackie viruses. , 1951, Postgraduate medicine.